In this blog post our Segment Leader for Life Science, Josh Guthrie, highlights the uses of psilocybin (a natural psychedelic prodrug compound), the integration of psilocybin research facilities into Canada, as well as the need for adequate air filtration in these facilities.
Since the legalization of medical marijuana in Canada, there have been an increasing number of questions regarding the legalization of other controlled drugs. In particular, there has been an emphasis placed on the legalization of psilocybin mushrooms (commonly known as magic mushrooms) due to possible mental health benefits that can be reaped from consumption. In examining the path that medical marijuana took in becoming accepted into Canadian society, it is apparent that psilocybin is following a similar trend and will likely move faster thanks to its predecessor.
What Are the Laws Surrounding the Use of Psychedelic Drugs In Canada?
As of January 5th, 2022, Health Canada has “given the green light for psychedelic drugs such as MDMA and magic mushrooms to be used for medical purposes”1 and Health Canada’s Special Access Programme (SAP) will allow medical practitioners to request access to previously illegal psychoactive substances for patients2.
This comes as a new amendment reverses a 2013 policy preventing the authorization of new drugs that is or contains a restricted drug.
Follow the story here